Company Profile

AngioLab Inc is a Korea-based company principally engaged in the manufacture and sale of pharmaceuticals. The Company manufactures and sells finished health functional food products using lemon balm extract mixed powder as the main ingredient, and health functional food raw materials such as lemon balm extract mixed powder. In addition, the Company develops pharmaceutical products and health functional foods based on angiogenesis inhibition.

Employees

Sector

Food Processing

More about the company

Quotes

Date	Price	Change	Volume
26-08-05	₩1,702.00	-6.99%	2,667
26-08-04	₩1,830.00	+1.67%	11,309
26-08-03	₩1,800.00	+0.28%	143
26-07-31	₩1,795.00	+5.59%	56
26-07-30	₩1,700.00	-3.85%	52

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. Other stock markets 2026-08-05			5-day change	1st Jan Change
1,702.00 ^KRW	-6.99%		-3.73%	-30.81%

21-11-29	Angiolab, Inc. announced that it has received KRW 5.499987 billion in funding from Smart CKD Bio-Healthcare No.1 Venture Investment Association, New Wave No. 6 Investment Association, Sori Asset Co., Ltd.	CI
21-11-16	Angiolab, Inc. announced that it expects to receive KRW 5.499987 billion in funding from Smart CKD Bio-Healthcare No.1 Venture Investment Association, New Wave No. 6 Investment Association, Sori Asset Co., Ltd.	CI

21-11-29	Angiolab, Inc. announced that it has received KRW 5.499987 billion in funding from Smart CKD Bio-Healthcare No.1 Venture Investment Association, New Wave No. 6 Investment Association, Sori Asset Co., Ltd.	CI
21-11-16	Angiolab, Inc. announced that it expects to receive KRW 5.499987 billion in funding from Smart CKD Bio-Healthcare No.1 Venture Investment Association, New Wave No. 6 Investment Association, Sori Asset Co., Ltd.	CI
20-09-23	Hanyang Securities Co., Ltd., Investment Arm and Sun-Tae Kim acquired 2.9% stake in Angiolab, Inc. from KB 12-1 Venture Fund of KB Investment Co., Ltd. for KRW 1.2 billion.	CI
20-09-17	Angiolab, Inc. cancelled the acquisition of NH Special Purpose Acquisition 13 Co., Ltd. from BNK Venture Investment and others in a reverse merger transaction.	CI
20-06-28	Angiolab, Inc. signed a contract to acquire NH Special Purpose Acquisition 13 Co., Ltd. from BNK Venture Investment and others in a reverse merger transaction for KRW 66.3 billion.	CI
19-07-18	Angiolab, Inc. announced that it has received KRW 2.999988 billion in funding from Dt& Investment Co.,Ltd.	CI
19-06-27	Angiolab, Inc. announced that it expects to receive KRW 2.999988 billion in funding from Dt& Investment Co.,Ltd. and another investor	CI
18-04-15	Angiolab, Inc. announced that it has received KRW 646.1616 million in funding from Yuanta Venture Capital Corp.	CI
14-10-08	Angiolab, Inc. announced that it has received KRW 1 billion in funding from Yuanta venture capital.	CI

1 day	-6.99%
1 week	-3.73%
Current month	-5.18%
1 month	-10.23%
3 months	-3.84%
6 months	-31.09%
Current year	-30.81%

1 week	1,600	2,070
1 month	1,600	2,070
Current year	1,523	2,700
1 year	1,523	4,635
3 years	1,523	9,200
5 years	1,523	12,300
10 years	1,523	25,800

Angiolab, Inc. Stock

Stocks

A251280

KR7251280004

Food Processing

Chart: Angiolab, Inc.

Latest news : Angiolab, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Angiolab, Inc.

Special Foods & Wellbeing Products

Company Profile

Quotes

Manager	Title	Age	Since
Min-Yeong Kim CEO	Chief Executive Officer	69	1999-06-02
Il-Hwan Jo PRN	Corporate Officer/Principal	65	-
Byeong-Yeong Park CTO	Chief Tech/Sci/R&D Officer	57	2016-07-26

Director	Title	Age	Since
Min-Yeong Kim BRD	Director/Board Member	69	1999-06-02
Byeong-Yeong Park BRD	Director/Board Member	57	2016-07-26
Il-Hwan Jo BRD	Director/Board Member	65	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ANGIOLAB, INC.	-6.99%	-3.73%	-58.99%	-77.61%	4.48M
ZHEJIANG NHU COMPANY LTD.	-1.03%	-1.65%	+34.05%	+81.82%	13.69B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+1.71%	0.00%	-26.30%	+268.63%	7.71B
BYHEALTH CO., LTD	+0.49%	+1.18%	-13.45%	-51.32%	2.54B
BELLRING BRANDS, INC.	-1.10%	-5.12%	-65.15%	-64.78%	1.48B
HERBALIFE LTD.	-1.56%	+0.72%	+33.19%	-32.29%	1.33B
XIAMEN KINGDOMWAY GROUP COMPANY	-1.12%	+2.24%	-30.38%	-25.97%	1.29B
JAMIESON WELLNESS INC.	-0.12%	-1.28%	+21.24%	+49.50%	1.23B
TSI GROUP CO., LTD.	+0.73%	-0.46%	-37.06%	-	1.14B
THE SIMPLY GOOD FOODS COMPANY	-1.32%	+9.07%	-62.76%	-70.82%	1B
Average	-1.03%	+0.85%	-20.56%	+8.57%	3.14B
Weighted average by Cap.	-0.18%	+0.47%	+1.86%	+95.02%